Empire Financial Management Company, LLC Gilead Sciences, Inc. Transaction History
Empire Financial Management Company, LLC
- $324 Billion
- Q1 2025
A detailed history of Empire Financial Management Company, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 2,600 shares of GILD stock, worth $276,016. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,600
Previous 2,600
-0.0%
Holding current value
$276,016
Previous $240 Million
21.31%
% of portfolio
0.09%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,284Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.5 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.32 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.8 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.68 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...